← Back to Conditions

Conduction disorder of the heart

disorder
SNOMED 44808001CUI C0003811

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Tocainide hydrochloride

substance

Quinidine polygalacturonate

substance

Flecainide acetate

substance

Procainamide hydrochloride

substance

Papaverine hydrochloride

substance

Disopyramide phosphate

substance

Amiodarone hydrochloride

substance

Lidocaine hydrochloride

substance

Quinidine gluconate

substance

Encainide hydrochloride

substance

Quinidine sulfate

substance

Alprenolol

substance

Moricizine hydrochloride

substance

Ibutilide fumarate

substance

Mexiletine hydrochloride

substance

Propafenone hydrochloride

substance

Dofetilide

substance

Sotalol hydrochloride

substance

Tocainide

substance

Ibutilide

substance

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Cardiac arrhythmias
HP:0011675
Sudden death
HP:0001699
Syncope
HP:0001279

Related Conditions

Heart block(child)
Congenital conduction defect(child)
Atrioventricular conduction disorder(child)
Familial dilated cardiomyopathy with conduction defect due to lamin A/C mutation(child)
Arrhythmia(parent)

Quick Facts

SNOMED CT
44808001
UMLS CUI
C0003811
Fully Specified Name
Conduction disorder of the heart (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
3
Known Treatments
20
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.